Description

NSE admits 6,751 additional equity shares of Vasa Denticity Limited (symbol: DENTALKART) allotted under ESOP to dealings on the SME EMERGE segment, effective April 02, 2026.

Summary

NSE has admitted 6,751 additional equity shares of Vasa Denticity Limited (trading symbol: DENTALKART) to dealings on the Capital Market segment under SME EMERGE, effective April 02, 2026. The shares were allotted under an Employee Stock Option Plan (ESOP) on February 19, 2026, with a face value of Rs. 10 each.

Key Points

  • 6,751 equity shares of Rs. 10/- each allotted under ESOP are listed on NSE SME EMERGE
  • Trading symbol: DENTALKART, Series: SM
  • ISIN: INE0N5801013 (temporary ISIN IN8********* per SEBI circular for dematerialized credits pending activation)
  • Distinctive number range: 17336799 to 17343549
  • Market lot size: 250 shares
  • Shares are pari passu with existing equity shares
  • No lock-in applicable

Regulatory Changes

No regulatory changes introduced. The listing is in pursuance of:

  • Regulation 3.1.1 of the NSE (Capital Market) Trading Regulations Part A — admission of securities to dealings
  • Regulation 2.5.5 of the NSE (Capital Market) Trading Regulations Part A — lot size specification

Compliance Requirements

  • Trading members must use the designated security code (DENTALKART) for all trades
  • Trading must be conducted in the specified market lot size of 250 shares
  • ISIN activation is subject to SEBI circulars CIR/MRD/DP/21/2012 (August 02, 2012) and CIR/MRD/DP/24/2012 (September 11, 2012) for additional issue of shares

Important Dates

  • Date of Allotment: February 19, 2026
  • Circular Date: April 01, 2026
  • Effective Date for Trading: April 02, 2026

Impact Assessment

Minimal market impact. This is a routine ESOP share listing for a small-cap SME EMERGE company. The issuance of 6,751 shares is a marginal addition to the existing share capital of Vasa Denticity Limited and does not signal any significant corporate event or policy change. Existing shareholders face negligible dilution. No action required by general market participants.

Impact Justification

Routine ESOP share listing for a small SME EMERGE company involving only 6,751 shares; no regulatory changes or broad market impact.